General : Delayed Poison Registry Updates Hamper Synthetic Drug Probes - Saifuddin Nasution

Malaysia fight against the burgeoning synthetic drug crisis is being severely hampered by bureaucratic delays in updating its Poisons Act 1952, according to Home Minister Datuk Seri Saifuddin Nasution Ismail. The minister revealed on June 13 that enforcement agencies face critical challenges taking legal action when new toxic chemical compounds, often found in dangerous synthetic narcotics like the recently identified 'Piu Piu', are not yet officially listed under the Act, creating significant loopholes for traffickers. This legislative lag is allowing sophisticated drug syndicates to outpace regulatory efforts, intensifying public health and security risks nationwide. The stakes are alarmingly high: synthetic drugs now account for a staggering 70% of all addiction cases in Malaysia, with Amphetamine-Type Stimulants (ATS) alone representing 73.9% of drug abuse incidents. The emergence of 'Piu Piu' – a potent concoction of fentanyl and other psychoactive chemicals often laced into vape liquids – has even prompted calls for a total vape ban from Deputy Inspector-General of Police Ayob Khan Mydin Pitchay, highlighting the evolving and insidious methods used by traffickers. While the Poisons Act underwent amendments in 2022 to enhance penalties and enforcement powers, the core issue lies in the sluggish administrative process of gazetting newly identified substances, a process that requires urgent inter-ministerial coordination. Moving forward, immediate action from the Cabinet, specifically enhanced coordination between the Home Ministry, Health Ministry, and Chemistry Department, is crucial to fast-track the scheduling of these dangerous compounds. The National Anti-Drugs Agency (AADK) has already begun deploying new detection kits for fentanyl and synthetic cannabinoids in vape liquids as of June 2026, but their effectiveness hinges on a robust legal framework that can keep pace with drug evolution. Without swifter legislative updates, Malaysia risks further escalation of its synthetic drug problem, leaving enforcement agencies perpetually a step behind the criminal networks that exploit these regulatory gaps.